IV administration produces direct systemic exposure, but evidence for elective wellness benefits remains limited
Long-term safety: While short-term safety profiles are generally favorable, long-term data on the safety of GLP-1 agonists, especially in non-diabetic populations, is still being gathered
Motley R, Kersey P, Lawrence C, et al
625 (sem 147) v .135 (sem 261) ng/ml) (Table 8)
Typically, a substance or method will be considered for the WADA Prohibited List if the substance or method meets any two of the following three criteria: It has the potential to enhance or enhances sport performance It represents an actual or potential health risk to the athlete It violates the spirit of sport Have a question
The compound was selected from a series of quinolinium-based molecules studied for cell permeability, enzyme selectivity and inhibition of NNMT